Application of Machine Learning in Chronic Kidney Disease: Current Status and Future Prospects

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2024 Mar 28

PMID 38540181

Authors

Charlotte Delrue

Sander De Bruyne

Marijn M Speeckaert

Affiliations

Soon will be listed here.

Abstract

The emergence of artificial intelligence and machine learning (ML) has revolutionized the landscape of clinical medicine, offering opportunities to improve medical practice and research. This narrative review explores the current status and prospects of applying ML to chronic kidney disease (CKD). ML, at the intersection of statistics and computer science, enables computers to derive insights from extensive datasets, thereby presenting an interesting landscape for constructing statistical models and improving data interpretation. The integration of ML into clinical algorithms aims to increase efficiency and promote its adoption as a standard approach to data interpretation in nephrology. As the field of ML continues to evolve, collaboration between clinicians and data scientists is essential for defining data-sharing and usage policies, ultimately contributing to the advancement of precision diagnostics and personalized medicine in the context of CKD.

Citing Articles

A recursive embedding and clustering technique for unraveling asymptomatic kidney disease using laboratory data and machine learning.

Alqaissi E, Algarni A, Alshehri M, Alkhaldy H, Alshehri A Sci Rep. 2025; 15(1):5820.

PMID: 39962186 PMC: 11832896. DOI: 10.1038/s41598-025-89499-8.

Uncovering glycolysis-driven molecular subtypes in diabetic nephropathy: a WGCNA and machine learning approach for diagnostic precision.

Fan C, Yang G, Li C, Cheng J, Chen S, Mi H Biol Direct. 2025; 20(1):10.

PMID: 39838413 PMC: 11748251. DOI: 10.1186/s13062-025-00601-6.

Artificial Intelligence to Diagnose Complications of Diabetes.

Ayers A, Ho C, Kerr D, Cichosz S, Mathioudakis N, Wang M J Diabetes Sci Technol. 2024; 19(1):246-264.

PMID: 39578435 PMC: 11688687. DOI: 10.1177/19322968241287773.

Machine learning approaches for predicting and diagnosing chronic kidney disease: current trends, challenges, solutions, and future directions.

Gogoi P, Valan J Int Urol Nephrol. 2024; 57(4):1245-1268.

PMID: 39560857 DOI: 10.1007/s11255-024-04281-5.

A Comprehensive Review of Advanced Biomarkers for Chronic Kidney Disease in Older Adults: Current Insights and Future Directions.

Pradeep U, Chiwhane A, Acharya S, Daiya V, Kasat P, Sachani P Cureus. 2024; 16(9):e70413.

PMID: 39473640 PMC: 11519577. DOI: 10.7759/cureus.70413.

References

Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L . Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. 2011; 22(4):752-61. PMC: 3065230. DOI: 10.1681/ASN.2010040355. View

MacIsaac R, Jerums G . Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens. 2011; 20(3):246-57. DOI: 10.1097/MNH.0b013e3283456546. View

Pesce F, Diciolla M, Binetti G, Naso D, Ostuni V, Di Noia T . Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients. Nephrol Dial Transplant. 2015; 31(1):80-6. DOI: 10.1093/ndt/gfv232. View

Webster A, Nagler E, Morton R, Masson P . Chronic Kidney Disease. Lancet. 2016; 389(10075):1238-1252. DOI: 10.1016/S0140-6736(16)32064-5. View

Leung R, Wang Y, Ma R, Luk A, Lam V, Ng M . Using a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case-control cohort analysis. BMC Nephrol. 2013; 14:162. PMC: 3726338. DOI: 10.1186/1471-2369-14-162. View

Brier M, Gaweda A, Dailey A, Aronoff G, Jacobs A . Randomized trial of model predictive control for improved anemia management. Clin J Am Soc Nephrol. 2010; 5(5):814-20. PMC: 2863987. DOI: 10.2215/CJN.07181009. View

Mueller B, Kinoshita T, Peebles A, Graber M, Lee S . Artificial intelligence and machine learning in emergency medicine: a narrative review. Acute Med Surg. 2022; 9(1):e740. PMC: 8887797. DOI: 10.1002/ams2.740. View

Manno C, Strippoli G, DAltri C, Torres D, Rossini M, Schena F . A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis. 2007; 49(6):763-75. DOI: 10.1053/j.ajkd.2007.03.013. View

Goto M, Kawamura T, Wakai K, Ando M, Endoh M, Tomino Y . Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm. Nephrol Dial Transplant. 2008; 24(4):1242-7. PMC: 2658733. DOI: 10.1093/ndt/gfn610. View

10.

Chen I, Pierson E, Rose S, Joshi S, Ferryman K, Ghassemi M . Ethical Machine Learning in Healthcare. Annu Rev Biomed Data Sci. 2021; 4:123-144. PMC: 8362902. DOI: 10.1146/annurev-biodatasci-092820-114757. View

11.

Xu J, Luo X, Wang G, Gilmore H, Madabhushi A . A Deep Convolutional Neural Network for segmenting and classifying epithelial and stromal regions in histopathological images. Neurocomputing (Amst). 2017; 191:214-223. PMC: 5283391. DOI: 10.1016/j.neucom.2016.01.034. View

12.

Molitch M, DeFronzo R, Franz M, Keane W, Mogensen C, Parving H . Nephropathy in diabetes. Diabetes Care. 2003; 27 Suppl 1:S79-83. DOI: 10.2337/diacare.27.2007.s79. View

13.

Shameer K, Johnson K, Glicksberg B, Dudley J, Sengupta P . Machine learning in cardiovascular medicine: are we there yet?. Heart. 2018; 104(14):1156-1164. DOI: 10.1136/heartjnl-2017-311198. View

14.

Hueso M, Vellido A, Montero N, Barbieri C, Ramos R, Angoso M . Artificial Intelligence for the Artificial Kidney: Pointers to the Future of a Personalized Hemodialysis Therapy. Kidney Dis (Basel). 2018; 4(1):1-9. PMC: 5848485. DOI: 10.1159/000486394. View

15.

Rodriguez-Romero V, Bergstrom R, Decker B, Lahu G, Vakilynejad M, Bies R . Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques. Clin Transl Sci. 2019; 12(5):519-528. PMC: 6742939. DOI: 10.1111/cts.12647. View

16.

Liang S, Zhang X, Cai G, Zhu H, Zhou J, Wu J . Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis. PLoS One. 2013; 8(5):e64184. PMC: 3653878. DOI: 10.1371/journal.pone.0064184. View

17.

Li Q, Fan Q, Han Q, Geng W, Zhao H, Ding X . Machine learning in nephrology: scratching the surface. Chin Med J (Engl). 2020; (6):687-698. PMC: 7190222. DOI: 10.1097/CM9.0000000000000694. View

18.

Martinez-Martinez J, Escandell-Montero P, Barbieri C, Soria-Olivas E, Mari F, Martinez-Sober M . Prediction of the hemoglobin level in hemodialysis patients using machine learning techniques. Comput Methods Programs Biomed. 2014; 117(2):208-17. DOI: 10.1016/j.cmpb.2014.07.001. View

19.

Choi R, Coyner A, Kalpathy-Cramer J, Chiang M, Campbell J . Introduction to Machine Learning, Neural Networks, and Deep Learning. Transl Vis Sci Technol. 2020; 9(2):14. PMC: 7347027. DOI: 10.1167/tvst.9.2.14. View

20.

Singh A, Szczech L, Tang K, Barnhart H, Sapp S, Wolfson M . Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006; 355(20):2085-98. DOI: 10.1056/NEJMoa065485. View